Therapeutic strategies and long-term results in differentiated thyroid cancer.
Differentiated thyroid carcinoma (DTC) is usually an indolent tumor associated with a low mortality. However, DTC, particularly papillary thyroid carcinoma, happens to be a multicentric tumor and tends to spread to the regional lymph nodes in the early stage of the disease; some patients with DTC do die from metastatic or recurrent disease. Despite the small number of these patients, therapeutic strategies designed to prevent such outcomes should be pursued. In this review, we attempt to evaluate the impact of different therapeutic strategies on survival and recurrence. Consequently, we conclude that the surgical approach to DIC should be individualized on the basis of the biologic behavior of the tumor, rather than on the extent of cancer involvement in the thyroid and regional lymph nodes. It is mandatory to expand our efforts to identify high-risk patients more accurately, thereby facilitating more rational approaches to treatment.
Noguchi
M
M
Department of Surgery (II), Kanazawa University Hospital, Japan.
Katev
N
N
Miwa
K
K
D003131:Combined Modality Therapy; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D013965:Thyroidectomy
D007455:Iodine